Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Soobratty, R. Whitfield, H. Milburn, G. Cope (Thornton Heath, London, United Kingdom). Time frame sensitivity of a point-of-care test to monitor isoniazid adherence in TB treatment. Eur Respir J 2009; 34: Suppl. 53, 2539

Member's Comments

No comment yet.

Related content which might interest you: Point-of-care urine test for assessing adherence to isoniazid treatment for tuberculosis Source: Eur Respir J 2014; 43: 1519-1522 Year: 2014 Comparison of genotype MTBDRplus assay for rapid detection of rifampicin and isoniazid resistance with conventional drug susceptibility tests in a tertiary care hospital in India Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 An audit of adherence to antituberculous drugs using a new, rapid, point of care test for isoniazid metabolites Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002 IP-10 point-of-care tests for monitoring treatment efficacy in tuberculosis in a low-resource setting Source: International Congress 2017 – Update on TB: latest news Year: 2017 Drug-susceptibility testing in tuberculosis: methods and reliability of results Source: Eur Respir J 2005; 25: 564-569 Year: 2005 Individualized treatment regimens with second line anti-TB drugs (SLD) compared to first line anti-TB drug (FLD) only in new pulmonary TB patients, culture confirmed with full sensibility at drug sensibility test (DST) Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Effect of HIV counseling and testing program on patients‘ adherence of isoniazid preventive therapy (IPT) Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005 Treatment efficacy of MDR TB based on drug susceptibility testing with microchip technology Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002 Patient choice promotes adherence in preventive treatment for latent tuberculosis Source: Eur Respir J 2007; 30: 728-735 Year: 2007 Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Completion rates of LTBI treatment: shifting prescription from INH alone to RIF containing regimens. Observation from 1992 to 2017 Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019 Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study Source: Eur Respir J 2015; 46: 567-570 Year: 2015 Evaluation of therapeutic response in isoniazid resistant TB Source: Eur Respir J 2006; 28: Suppl. 50, 846s Year: 2006 Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method Source: Eur Respir J 2016; 48: 1160-1170 Year: 2016 A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 571-574 Year: 2015 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 569-571 Year: 2015 Evaluation of patient adherence to tuberculosis treatment by measuring drug metabolites in urine Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004 Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006